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Abstract
Innate immune responses are essential for controlling poxvirus infection. The threat of a bioterrorist attack using Variola
major, the smallpox virus, or zoonotic transmission of other poxviruses has renewed interest in understanding interactions
between these viruses and their hosts. We recently determined that TLR3 regulates a detrimental innate immune response
that enhances replication, morbidity, and mortality in mice in response to vaccinia virus, a model pathogen for studies of
poxviruses. To further investigate Toll-like receptor signaling in vaccinia infection, we first focused on TRIF, the only known
adapter protein for TLR3. Unexpectedly, bioluminescence imaging showed that mice lacking TRIF are more susceptible to
vaccinia infection than wild-type mice. We then focused on TLR4, the other Toll-like receptor that signals through TRIF.
Following respiratory infection with vaccinia, mice lacking TLR4 signaling had greater viral replication, hypothermia, and
mortality than control animals. The mechanism of TLR4-mediated protection was not due to increased release of
proinflammatory cytokines or changes in total numbers of immune cells recruited to the lung. Challenge of primary bone
marrow macrophages isolated from TLR4 mutant and control mice suggested that TLR4 recognizes a viral ligand rather than
an endogenous ligand. These data establish that TLR4 mediates a protective innate immune response against vaccinia virus,
which informs development of new vaccines and therapeutic agents targeted against poxviruses.
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Introduction
In 1980, the World Health Organization declared that smallpox
had been eliminated as a human disease [1]. Nevertheless,
potential bioterrorist release of Variola major, the causative agent
for smallpox, and human infection with monkeypox or other
zoonotic orthopoxviruses has heightened interest in this family of
viruses [2]. Variola major is particularly feared as a bioterrorism
agent because of the high rate of transmission and up to 30%
mortality caused by smallpox [3]. Fatal cases of smallpox were
characterized by clinical findings similar to septic shock, likely
mediated by the host inflammatory response to infection.
However, molecules and signaling pathways that initiate and
control protective and detrimental immune responses to Variola
major remain poorly defined. Identifying molecular determinants of
the innate immune response to poxviruses is critical to under-
standing pathogenesis of poxvirus infections and developing better
therapies to prevent or ameliorate the sepsis-like disease
manifestations. This knowledge also may lead to development of
a safer smallpox vaccine that eliminates the high risk of severe, life-
threatening complications associated with the current live,
attenuated vaccinia virus vaccine. Improved understanding of
the innate immune response to poxviruses will have benefits
beyond advancing new vaccines and therapies to prevent and treat
infection. Vaccinia virus is being investigated as a gene delivery,
oncolytic, or immunizing vector for a wide variety of diseases,
including cancer, HIV and malaria [4–8]. Greater knowledge of
normal host-pathogen interactions will enable more efficient
targeting and efficacy of these vectors in patients. Finally, insights
gained from studying pulmonary infection with poxviruses are
expected to inform research on protective and harmful aspects of
host immunity to other respiratory pathogens.
Toll-like receptors (TLRs) have emerged as key molecules in
initiating innate immune responses to a variety of different
pathogens, and these receptors also regulate subsequent adaptive
immune responses to infection. TLRs recognize defined molecular
patterns associated with various pathogens, including bacteria,
fungi, and viruses. In vitro studies have identified canonical ligands
for different TLR family members, such as double-stranded RNA
for TLR3 and bacterial lipopolysaccharide (LPS) for TLR4.
However, recent studies suggest that TLRs may respond to a
broader range of molecular patterns. For example, while TLR4-
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regulator of effective host immunity to bacterial pathogens, TLR4
also may signal in response to a wide variety of endogenous
ligands, such as heat shock proteins [9,10]. TLR4 also may
respond to some viral proteins, and TLR4-dependent signaling
may be necessary to limit viral replication and disease morbidity in
vivo [11,12]. These studies emphasize that functions of TLRs in
host immunity may extend to pathogens that do not carry known
ligands for specific receptors, particularly as TLRs respond to
infections in living animals.
We recently established that TLR3 controls a detrimental
innate immune response to pulmonary infection with vaccinia
virus, a model virus for studies of orthopoxviruses [13]. Compared
with wild-type mice, mice lacking TLR3 (TLR3
2/2) had reduced
viral replication and were protected against disease morbidity and
mortality. Adverse effects of TLR3 signaling were caused in part
by an excessive inflammatory response to infection. To further
investigate TLR3 in poxvirus infection, we initially focused on
functions of TIR domain-containing adapter inducing interferon-b
(TRIF), the only known downstream adapter molecule for TLR3.
Unexpectedly, mice lacking TRIF (TRIF
2/2) did not reproduce
protective effects of deleting TLR3, but TRIF
2/2 was more
susceptible to vaccinia infection. These data prompted us to
analyze functions of TLR4, the only other TLR known to signal
through TRIF, in response to respiratory infection with vaccinia
virus. We determined that TLR4 signaling protects mice against
vaccinia infection, limiting viral replication and local inflamma-
tion.
Results
TRIF
2/2 mice have a distinct phenotype from TLR3
2/2
mice
We recently reported that TLR3
2/2 mice are protected from
pulmonary vaccinia infection compared to wild type C57BL/6
controls [13]. The only known adaptor molecule for TLR3 is
TRIF, so TLR3 is thought to signal exclusively through TRIF to
control secretion of type I interferons and pro-inflammatory
cytokines [14]. Because of this direct TLR3 to TRIF signaling
pathway, we hypothesized that TRIF
2/2 mice would be protected
against vaccinia infection, similar to TLR3
2/2 mice.
We infected TRIF
2/2 and wild-type C57BL/6 mice with
1610
4 pfu Vac-GFL intransally (i.n.) to reproduce the natural
respiratory route of infection with Variola major. Vac-GFL is a
recombinant vaccinia virus that expresses a reporter protein
comprised of GFP fused to firefly luciferase [13], which allows viral
replication and dissemination to be quantified in living mice using
bioluminescence imaging. We previously established that in vivo
measurements of bioluminescence from Vac-GFL correlate
directly with viral titers in a defined organ or tissue [15].
Bioluminescence imaging was performed daily to monitor
replication of vaccinia virus, and weight loss was used as marker
for systemic severity of disease.
Unexpectedly, susceptibility of TRIF
2/2 mice to vaccinia
infection was distinct from that of the TLR3
2/2 mice. TRIF
2/2
mice had less weight loss than wild-type mice on days 1–4 post-
infection (p,0.05), which is similar to our published results for
TLR3
2/2 versus wild-type mice, (Figure 1A). However, TRIF
2/2
mice differed from TLR3
2/2 animals in that replication of Vac-
GFL was greater in mice lacking TRIF, as quantified by region of
interest analysis of head, chest, and abdomen sites on biolumines-
cence images. By area under the curve (AUC) analysis, TRIF
2/2
mice had significantly greater luminescence in their chests (from
lung infection) than wild-type mice (Figure 1B; p,0.01). These data
indicate that a different and/or additional host molecule(s) controls
responses to vaccinia in TRIF
2/2 mice relative to those mediated
solely by TLR3. This experiment continued until day 7 post-
infection, when the animals were euthanized to obtain plasma and
bronchoalveolar (BAL) fluid for quantification of cytokines. Levels
ofIL-6,IL-4,IFN-c,MCP-1,TNF-a,and TGF-bweremeasuredin
these samples, but no significant differences were seen between the
TRIF
2/2 and WT mice (data not shown).
TLR4 confers protection in pulmonary vaccinia infection
We hypothesized that TLR4, the only other Toll-like receptor
known to signal through TRIF, may control differing host
responses to vaccinia in TLR3
2/2 versus TRIF
2/2 mice. TLR4
is reported to limit replication of a limited number of viruses
[11,16], although functions of this receptor in vaccinia infection
have not been established. To investigate TLR4 in host defense
against vaccinia virus, we used C3H/HeJ mice, which have a
point mutation in the cytoplasmic region of TLR4 that renders
them unresponsive to LPS [17]. As controls, we used C3HeB/FeJ
mice, which have normal, functional TLR4. C3HeB/FeJ mice are
genetically similar to C3H/HeJ mice and are well-established as a
control strain for experiments using C3H/HeJ animals [18–20].
We infected C3H/HeJ and C3HeB/FeJ mice with 1610
4 pfu
Vac-GFL. Systemic effects of disease were monitored by weight
loss and rectal temperature, while viral replication and spread
were assessed with bioluminescence imaging. While both strains of
mice lost body temperature in response to vaccinia infection [21],
temperatures decreased to a greater extent over the course of the
infection in C3H/HeJ (TLR4 mutant) mice relative to C3HeB/
FeJ (Figure 2A). C3H/HeJ mice had a slightly lower temperature
than the controls prior to infection, but there were no differences
between strains on days 1, 2, and 3 post-infection. Beginning on
day 4, however, rectal temperatures were significantly lower in
C3H/HeJ mice, reaching a mean temperature of 33uC on day 6
post-infection (p,0.05). In contrast, the lowest mean temperature
recorded in C3HeB/FeJ mice was 34.7uC on day 7. C3H/HeJ
mice had significantly lower temperatures than control C3HeB/
FeJ mice on days 4–7 (p,0.05). As a second marker of disease
severity, weight loss was monitored over the course of the disease
Author Summary
Toll-like receptors are a class of transmembrane proteins
that detect the presence of infectious organisms and
activate host innate and adaptive immune responses.
Vaccinia virus is the prototypic poxvirus, and it is used as
both a model and a vaccine for the virus that causes
smallpox. We recently reported that Toll-like receptor 3
(TLR3), which recognizes double-stranded RNA, acts in
vaccinia infection in a way that is detrimental to the host.
TLR3 relays its signal to the nucleus using the adaptor
protein TRIF. In this paper, we report that mice lacking TRIF
are more susceptible to vaccinia infection than wild-type
controls. TLR4 also uses TRIF to relay its signals. We report
our findings that TLR4 has a protective effect in vaccinia
infection. Mice with a nonfunctional mutant version of
TLR4 are more susceptible to vaccinia infection than wild-
type controls. The protection that TLR4 affords is not due
to effects on secretion of proinflammatory cytokines or
type I interferon, and the receptor also does not uniquely
regulate recruitment of white blood cells to the site of
infection. Rather, TLR4 recognizes a molecule in or on
vaccinia virus to bring about a protective response that
may be due to an ability to diminish the degree of
inflammation caused by vaccinia infection.
TLR4 Limits Vaccinia Infection in Mice
PLoS Pathogens | www.plospathogens.org 2 September 2008 | Volume 4 | Issue 9 | e1000153(Figure 2B). Surprisingly, the TLR4 mutant mice lost slightly less
weight than the controls with significant differences on days 1–3
and 7–8 post-infection (p,0.05). Although the pattern of the
weight loss difference is opposite that of the body temperature, it is
consistent with the reduced weight loss observed in TLR3
2/2 and
TRIF
2/2 mice compared with wild-type controls.
Bioluminescence imaging showed that C3H/HeJ (TLR4
mutant) mice had significantly greater viral replication in the
chest region on days 1, 4, and 5 post-infection (p,0.05; Figure 2C).
Light measured in the chest region of interest predominantly
represents viral replication in the lung. C3H/HeJ mice also had
significantly more Vac-GFL bioluminescence in the chest over the
full course of the experiment as determined by AUC analysis.
AUC values for bioluminescence were 1.61610
8 vs. 3.18610
7 for
C3H/HeJ and C3HeB/FeJ mice, respectively (p,0.01). C3H/
HeJ mice also had increased abdominal luminescence compared
to control animals on day 4 (p,0.05) and over the course of the
experiment by AUC analysis (Figure 2D). AUC values for photons
produced in abdominal regions were 1.68610
7 and 5.21610
6 for
C3H/HeJ and control C3HeB/FeJ mice, respectively (p,0.05).
Bioluminescence in the head region did not differ between groups,
and all mice recovered from infection (data not shown).
Collectively, these data suggest that TLR4 limits respiratory
infection and systemic spread of vaccinia virus.
To establish effects of TLR4 on survival, we infected C3H/HeJ
and control C3HeB/FeJ mice with 5610
5 pfu Vac-GFL, a dose
1.5 logs higher than used previously. Using this inoculum, TLR4
mutant mice were clearly more susceptible to vaccinia infection.
By day 10 post-infection, 70% of C3H/HeJ mice had died, while
all control mice recovered from infection (Figure 3A). As in the
previous experiment, loss of body temperature was measured as a
sign of morbidity. C3H/HeJ mice were significantly more
hypothermic than control C3HeB/FeJ mice on days 2 and 5–9
post-infection (p,0.05; Figure 3B). The rapid recovery of mean
temperature in C3H/HeJ mice between days 9 and 10 is caused
by death of the most hypothermic mice, while the surviving
animals recovered temperature comparable to control C3HeB/
FeJ mice. These data were consistent over 5 independent
experiments. Weight loss also was monitored over the course of
the disease. C3H/HeJ mice exhibited less weight loss than control
C3HeB/FeJ animals over the first 7 d post-infection, and these
differences were significant on days 2–4 and 6 (p,0.05; Figure 3C).
The same trend was observed in two subsequent experiments.
However, C3H/HeJ mice recovered weight more quickly than
control C3HeB/FeJ animals on days 8–13, with significant
differences observed on days 12 and 13 (p,0.05). Both body
temperature and weight loss are reported to be regulated by
cytokines, including IL-1, IL-6, and TNF-a, as part of the
‘‘sickness response’’ [22]. The discrepancy between these param-
eters during vaccinia infection suggests underlying differences in
mechanisms and pathways that regulate these two global measures
of disease. These data highlight limitations of using weight loss
alone as a measure of disease severity in vaccinia infection.
With an inoculum of 5610
5 pfu Vac-GFL, differences in viral
replication between genotypes were even more pronounced than in
theearlierexperiment.Bioluminescencefrom Vac-GFLwas greater
in the head region of C3H/HeJ mice compared with controls.
Differences between strains were statistically significant over the
latter part of infection on days 5 and 7–10 (p,0.05; Figure 4A).
Over the course of the experiment, there was a trend for higher
head bioluminescence in C3H/HeJ mice as determined by AUC
analysis, although this difference was not statistically significant.
Similarly, bioluminescence in the chests of TLR4 mutant mice was
significantly increased over the controls (p,0.05) on days 3–7 and
10 post-infection (Figure 4B,C). At the peak of infection on day 6,
the chest luminescence of the TLR4 mutant mice was 8-fold higher
than that of the control mice. Moreover, the AUC for biolumines-
cence in C3H/HeJ TLR4 mutant mice was significantly greater
than that for controls (7.22610
8 vs. 8.20610
7, respectively;
p,0.05). Increased viral replication in lungs of C3H/HeJ was also
confirmed by plaque assay (Figure 5). Finally, C3H/HeJ mice had
greater systemic spread of the virus to the abdomen (Figure 6A and
6B). At the peak on day 5, the TLR4 mutant mice had 4.7-fold
higher luminescence in the abdomen than wild-type controls.
Differences between the two genotypes were significant on days 3–8
post-infection. The AUC of the abdominal luminescence in the
C3H/HeJ mice was 4.39610
7 compared with 9.39610
6 in the
control C3HeB/FeJ mice, respectively (p,0.05). These data extend
our initial observations of increased viral replication and dissem-
ination in mice lacking functional TLR4. Taken together, loss of
functional TLR4 renders C3H mice more susceptible to pulmonary
vaccinia infection, as measured by multiple parameters. Therefore,
TLR4 must recognize some exogenous or endogenous ligand
present in vaccinia infection.
To exclude the possibility of our results being affected by
endotoxin contamination of our viral preparation, we infected
RAW cells with Vac-GFL in the presence or absence of 10 mg/mL
polymyxin B [23]. Levels of IL-6, TNF-a, and MCP-1 in the cell
culture supernatants were assayed by ELISA. Adding polymyxin B
did not affect levels of IL-6, MCP-1, or TNF-a in the supernatants
of infected cells (data not shown), establishing that contaminating
endotoxin did not affect our in vivo studies.
Figure 1. TRIF
2/2 mice are more susceptible to vaccinia
infection than WT. TRIF
2/2 and WT BL/6 mice were infected with
1610
4 pfu Vac-FL. (A) Weight loss, expressed as percent of initial
weight. *p,0.05. (B) Chest luminescence, expressed as photon flux.
Error bars denote SEM.
doi:10.1371/journal.ppat.1000153.g001
TLR4 Limits Vaccinia Infection in Mice
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Type I interferons are essential to effective host defense against
vaccinia infection [24]. TLR4 signaling results in production of
Type I interferons through activation of transcription factors
interferon regulatory factor 3 (IRF3) and NF-kB. To determine to
what extent TLR4 regulates secretion of type I interferons during
vaccinia infection, we measured concentrations of interferon-b
(IFN-b) in lung tissue of C3H/HeJ and control mice. Mice were
infected i.n. with 5610
5 pfu Vac-GFL, and lungs were harvested
on days 3 and 5 post-infection. The day 3 time point is early in the
course of infection, at the beginning, or just before, differences in
luminescence and body temperature appear. Day 5 is near the
peak of the infection where differences between TLR4 mutant and
control mice are most pronounced. Lungs were homogenized and
concentrations of IFN-b in supernatants were measured by
ELISA. Levels of IFN-b were below the limit of reliable detection
on day 3 in both groups of mice. On day 5 post-infection, IFN-b
levels in 8 of 9 control mice remained below the limit of detection.
On the other hand, six of 9 C3H/HeJ mice had IFN-b above the
limit of reliable detection on day 5 (Figure 7). Therefore, C3H/
HeJ mice are capable of producing IFN-b despite the lack of
TLR4 signaling, showing redundancy in signaling pathways that
activate a type I interferon response to vaccinia.
Loss of TLR4 does not eliminate the inflammatory
response to vaccinia in the lung
We hypothesized that protective effects of TLR4 may be
mediated by pro-inflammatory cytokine responses, limiting viral
replication and spread directly, or indirectly through recruitment
of immune cells. To test this hypothesis, we infected C3H/HeJ
and control mice with 5610
5 pfu Vac-GFL i.n. and harvested
lungs on days 3 and 5 post-infection. Supernatants from
homogenized lungs were analyzed by ELISA for IL-6, TNF-a,
and MCP-1. There were no significant differences in levels of any
of these cytokines between groups of mice on day 3. On day 5,
TNF-a and MCP-1 levels were the same in TLR4 mutant and
control mice, but IL-6 levels were significantly higher in C3H/HeJ
lungs (Figure 8). No significant differences were detected in the
plasma at either time (data not shown) (p.0.4). As with type I
interferon, redundant signaling pathways are able to elicit NF-kB-
dependent cytokine production in response to vaccinia infection.
To analyze the degree and composition of leukocyte infiltrates in
t h el u n g ,i m m u n ec e l l sw e r ei s o l a t e df r o mu n i n f e c t e dm i c ea n dm i c e
on days 3 and 5 post-infection. Numbers and types of cells were
analyzed by flow cytometry. At day 3, there was a trend towards
higher total CD45+ cells in the C3H/HeJ cell, but these differences
were not significant. We also measured subsets of immune cells in the
Figure 2. TLR4 mutant mice are more susceptible to vaccinia than controls. C3HeB/FeJ and C3H/HeJ mice were infected with 1610
4 pfu
Vac-GFL. (A) Body temperature. (B) Weight loss, expressed as percent of initial weight; (C) Chest luminescence. (D) Abdominal luminescence,
expressed as photon flux. *p,0.05. Error bars denote SEM.
doi:10.1371/journal.ppat.1000153.g002
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macrophages, dendritic cells, and neutrophils. However, there were
no consistent differences in cell types recruited to lungs of infected
C3H/HeJ and control C3HeB/FeJ mice (data not shown).
To further assess the pattern of inflammation and tissue damage
in TLR4 mutant lungs, we examined the lungs of vaccinia-infected
mice by histology. Hematoxylin and eosin–stained sections showed
foci of mixed and lymphocytic peribronchial and perivascular
infiltrate (Figure 9A and 9B). Occasionally, infiltrating cells could
be seen in alveoli separate from any peribronchial or perivascular
focus. In foci of severe inflammation, epithelial cell necrosis was
observed, and some inflammatory cells had apoptotic morphology.
As a quantitative measure of inflammation, numbers of foci in
each section were counted. On day 3 post-infection, the beginning
of the interval when increased levels of virus could be discerned in
lungs of TLR4 mutant mice, C3H/HeJ TLR4 mutant mice had
significantly more foci of inflammation than controls (p,0.05;
Figure 10). No consistent differences were detected on day 5.
These data indicate that TLR4 is not required for producing an
early local inflammatory response to vaccinia infection.
Vaccinia predominantly infects epithelial cells in the lung
To investigate the cell type(s) involved in the propagation of
infection in the lungs, we performed immunohistochemical
staining on paraffin-embedded lung sections with anti-GFP. Mice
were infected with 5610
5 pfu Vac-GFL, and lungs were harvested
on days 3 and 5 post-infection. In all samples, intense anti-GFP
staining was localized to bronchial epithelial cells with less
extensive infection detected in alveolar epithelial cells (Figure 11A
and 11B). Samples of both genotypes also showed some staining of
cells among the inflammatory infiltrate, possibly macrophages,
although firm identification could not be made. In all samples, the
regions of positive anti-GFP antibody staining were associated with
foci of inflammation, but many foci of inflammation had no
regions of anti-GFP antibody staining. The distribution and types
of infected cells did not differ between strains of mice. These
findings suggest that in the lungs, vaccinia primarily replicates and
spreads through epithelial cells.
TLR4 recognizes a viral particle ligand
In order to determine whether TLR4 was signaling in response
to an endogenous or a viral ligand, we treated bone marrow
macrophages isolated from C3H/HeJ and control mice with live
or UV-inactivated virus (MOI=5), and measured levels of TNF-a
and IL-6 in the supernatant. The undiluted stock of UV-
inactivated Vac-GFL (9.0610
7 pfu/mL) produced no plaques or
cytopathic effect in cultured Vero cells (data not shown). TLR4
mutant and control macrophages were equally resistant to viral
Figure 3. Increased susceptibility of TLR4 mutant mice is more pronounced at higher viral dose. C3HeB/FeJ and C3H/HeJ mice were
infected with 5610
5 pfu Vac-GFL intranasally. (A) Survival curve, expressed as percentage of mice surviving. (B) Body temperature. (C) Weight loss,
expressed as percentage of initial weight. *p,0.05. Error bars denote SEM.
doi:10.1371/journal.ppat.1000153.g003
TLR4 Limits Vaccinia Infection in Mice
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(Figure 12A). TLR4 mutant and control macrophages treated with
UV-inactivated virus produced significantly (p,0.05) higher levels
of IL-6 and TNF-a than cells of the same genotype treated with
live virus (Figure 12B and 12C). This is likely due to the absence
vaccinia-encoded inhibitors of TLR and other signaling pathways,
such as N1L, A46R, and A52R [25–27], produced by replicating
vaccinia virus. TLR4 mutant macrophages produced significantly
higher levels of both IL-6 and TNF-a than control cells (p,0.05;
both live and UV-inactivated virus). This shows that TLR4 not
only is unnecessary for the cytokine response of bone marrow
macrophages to vaccinia virus, but it actually dampens that
response. C3H/HeJ (TLR4 mutant) cells treated with UV-
inactivated virus produced by far the highest levels of any
condition, rising above IL-6 levels in C3H/HeJ-with-live virus
cultures by 6- to 7-fold and 2- to 3-fold for TNF-a in the same
cells. Cytokine levels in UV-inactivated C3H/HeJ cultures were
approximately 6- to 10-fold higher than those in UV-inactivated
Figure 4. Increased viral replication in TLR4 mutant mice is more pronounced at higher viral dose. C3HeB/FeJ and C3H/HeJ mice were
infected with 5610
5 pfu Vac-GFL intranasally. (A) Head luminescence. (B) Chest luminescence. (C) Representative chest images. C3HeB/FeJ (left) and
C3H/HeJ (right), 30 s exposure, f-stop 1. Purple denotes lower luminescence intensity; red, higher luminescence intensity.*p,0.05. Error bars denote
SEM.
doi:10.1371/journal.ppat.1000153.g004
Figure 5. Increased viral titers in TLR4 mutant lungs. C3HeB/FeJ
and C3H/HeJ mice were infected with 5610
5 pfu Vac-GFL intranasally.
Lung viral titer expressed as pfu/mL; lungs harvested day 6 post-
infection. *p,0.05. Error bars denote SEM.
doi:10.1371/journal.ppat.1000153.g005
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produce TNF-a and IL-6 in response to UV-inactivated virus, and
that TLR4-intact macrophages produce significantly less of these
cytokines, indicates that neither viral replication nor cell death is
necessary for TLR4 recognition of vaccinia virus. This suggests
that TLR4 recognizes a component of the viral particle rather
than an endogenous ligand released from infected host cells.
Discussion
The innate immune system is vital for host defense against
poxviruses, but molecular mechanisms of virus recognition and
host defense are incompletely understood. While a robust Th1
immune response is necessary to eliminate vaccinia and other
poxviruses, an exaggerated innate immune response also may
threaten the life of the host. In septic shock, a systemic ‘‘cytokine
storm’’ causes blood vessel dilation and activation of the clotting
cascade, leading to hypotension, hemolysis, and multi-organ
failure. Severe and fatal cases of smallpox are characterized by
fever, hypotension, coagulopathy, blood vessel dilatation, and
leukocyte extravasation, all of which are resemble the pathophys-
iology of septic shock [3]. These observations, coupled with the
absence of lesions from any location except the skin, suggest that
an uncontrolled systemic immune response is the most dangerous
aspect of poxvirus infection.
As one mechanism through which immunity contributes to
disease manifestations of poxviruses, we recently reported that
TLR3 has a detrimental effect in vaccinia infection [13].
Specifically, mice lacking TLR3 had decreased viral replication,
morbidity, and mortality following infection with vaccinia virus.
Figure 6. Increased viral replication in TLR4 mutant abdomens is more pronounced at higher viral dose. C3HeB/FeJ and C3H/HeJ mice
were infected with 5610
5 pfu Vac-GFL intranasally. (A) Abdominal luminescence. (B) Representative images of splenic luminescence C3HeB/FeJ (left)
and C3H/HeJ (right) mice, 30 s exposure, f-stop 1. Purple denotes lower luminescence intensity; red, higher luminescence intensity.*p,0.05. Error
bars denote SEM.
doi:10.1371/journal.ppat.1000153.g006
TLR4 Limits Vaccinia Infection in Mice
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pathogenesis and highlight the critical balance between effective
and excessive innate immune responses during poxvirus infection.
To further investigate signaling pathways by which TLR3
exacerbates poxvirus disease, we first analyzed vaccinia infection
in mice lacking TRIF, the only known adapter protein for TLR3.
Unlike TLR3
2/2 mice, viral replication was significantly greater
in TRIF
2/2 mice relative to wild-type animals. These data
suggested the possibility that protective effects of TRIF against
vaccinia infection were mediated through TLR4. Besides TLR3,
TLR4 is the only other TLR known to use TRIF as a signaling
adaptor. Although TLR4 canonically recognizes bacterial LPS,
this receptor also has been implicated in host defense against some
viruses. For example, TLR4 is reported to recognize respiratory
syncytial virus (RSV) protein F or vesicular stomatitis virus (VSV)
glycoprotein G, thereby initiating protective innate immune
responses [11,16].
Unlike TLR3, TLR4 does not rely on TRIF exclusively, but also
can signal through the adaptor myeloid differentiation factor 88
(MyD88). We hypothesized that in TLR3
2/2 mice, the normal
inflammatory response was attenuated sufficiently to minimize
injury to the host while still eliminating vaccinia virus. In TRIF
2/2
mice,wereasoned thatsignalinginputsfrom TLR3 andTLR4 were
both blocked, thus decreasing the inflammatory response to such a
degree that the host was not able to make an effective defense
againstthevirus.Consistentwith thishypothesis,wedemonstrated a
protective effect for TLR4 in pulmonary vaccinia infection. Mice
withan inactivatingmutation in TLR4 suffered increased mortality,
more severe hypothermia, and increased viral replication in the
head, chest, and abdomen. Further investigation into the mecha-
nism of this protection, however, revealed a more complicated
picture.
The TLR4 signaling pathway results in activation of NF-kB and
interferon regulatory factor 3, suggesting that TLR4-deficient mice
would have increased viral replication because of impaired
cytokine production and recruitment of immune cells to the lung
and other sites of infection. However, levels of TNF-a, MCP-1, IL-
6, and IFN-b in TLR4 mutant mice were equal to or even greater
than those of the controls. Moreover, histological examination of
infected lungs showed that TLR4 mutant mice had significantly
more foci of inflammation in their lungs than did controls as early
as day 3 post-infection. The results suggest either that TLR4 does
not function in these aspects of host immunity to vaccinia virus or
that other pattern recognition receptors compensate for loss of
Figure 7. Lack of TLR4 does not impair IFN-b production. IFN-b concentrations in lung homogenate supernatants were measured by ELISA.
Points represent individual mice. Dashed line represents lower limit of reliable detection on standard curve. Solid lines represent mean IFN-b
concentration.
doi:10.1371/journal.ppat.1000153.g007
Figure 8. Lack of TLR4 does not impair proinflammatory cytokine production. IL-6 levels in the lung homogenate supernatants measured
by ELISA. Error bars denote SEM. *p,0.05.
doi:10.1371/journal.ppat.1000153.g008
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TLR2 and TLR9 in poxvirus infection [28,29]. The fact that the
TLR4 mutant mice are still more susceptible to disease indicates
that other pattern recognition receptors are not fully redundant to
TLR4 in poxvirus infection.
Immunohistochemical staining revealed vaccinia infection
predominantly in bronchiolar epithelium with lesser amounts of
viral GFP in alveolar epithelial cells. These data are consistent
with previous studies showing that respiratory infection with
poxviruses causes a necrotizing bronchopneumonia [30]. We also
identified viral GFP antigen in immune cells in the lung, likely
macrophages. Previous studies suggest that monocyte/ macro-
phage cell types are responsible for systemic spread of poxviruses
[30]. While we cannot exclude the possibility that GFP is present
in these cells because of phagocytosis rather than infection, our
data are compatible with a model in which cells in the monocyte
lineage are responsible for systemic dissemination of virus. The
observation that both genotypes exhibited a similar repertoire of
infected cells suggests that a difference in susceptibility of specific
cell types does not account for increased susceptibility of the TLR4
mutant mice.
Increased IL-6 and TNF-a levels in TLR4 mutant macrophages
treated with UV-inactivated virus show that viral replication and
cell damage are dispensable for TLR4 recognition of vaccinia.
This suggests that TLR4 recognizes a component of the viral
particle rather than a host ligand. In our model, the ligand
recognized by TLR4 likely would be located in/on the
intracellular mature virion (IMV) particle, the predominant form
of virus isolated by standard purification procedures such as those
used in this research. TLR4 predominantly localizes to the cell
Figure 9. TLR4 alters the inflammatory response to vaccinia
infection: representative photomicrographs. Mice were infected
intranasally with 5610
5 pfu Vac-GFL. Lungs were harvested on days 3
and 5 post-infection, preserved in 10% formalin, paraffin-embedded,
and stained with H&E. (A, B) representative sections of C3H/HeJ (A) and
C3HeB/FeJ (B) lung tissue obtained on day 3 post-infection. B=bron-
chiole; V=blood vessel; arrows denote inflammatory foci.
doi:10.1371/journal.ppat.1000153.g009
Figure 10. TLR4 alters the inflammatory response to vaccinia
infection: quantification of foci of inflammation. Data are
expressed as number of foci per section. *p,0.01. Error bars denote
SEM.
doi:10.1371/journal.ppat.1000153.g010
Figure 11. Vaccinia localizes to the bronchial and alveolar
epithelium. Lungs harvested from Vac-GFL-infected mice (5610
5 pfu)
on day 5 post-infection were stained with anti-GFP and counterstained
with hematoxylin. (A) Representative section of C3H/HeJ lung, 1506. (B)
Representative section of C3HeB/FeJ lung, 1506.
doi:10.1371/journal.ppat.1000153.g011
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surface of the intracellular mature virion. However, crosslinking
DNA in the viral genome with UV/psoralen treatment does not
prevent vaccinia from entering the cell and uncoating, so the
TLR4 ligand also could be a capsid protein or another protein
present in the viral particle.
Increased inflammation in TLR4 mutant mice may be
secondary to increased viral burden or a primary effect of the
loss of TLR4. Because TLR4 mutant macrophages secrete
increased levels of IL-6 and TNF-a even when challenged with
UV-inactivated virus, we propose that lack of TLR4 signaling
causes increased inflammation. This interpretation also is
supported by our data showing equal viral titers in TLR4 mutant
and control macrophage cultures infected with live virus despite
the higher cytokine levels in TLR4 mutant cell cultures. Consistent
with our observations in TLR3
2/2 mice, TLR4 may provide its
protection by dampening the inflammatory response elicited in
response to vaccinia infection.
In conclusion, this study demonstrates that TLR4 mediates a
protective immune response to vaccinia virus. To our knowledge,
it is the first to demonstrate such a role in the context of vaccinia
infection, adding to a growing body of literature showing that
TLR4 may respond to non-bacterial ligands and mediate
protective effects against viruses. These data also highlight the
complexity of TLR signaling in vivo in determining overall
outcomes of infection. As the TLR4 mutant mice had equal or
greater levels of interferon and proinflammatory cytokines in their
lungs, we cannot attribute their increased susceptibility to
impairment of TLR4-dependent interferon or cytokine produc-
tion. Protective effects of TLR4 also cannot be attributed to
altered or impaired effector cell recruitment or to increased
susceptibility of a specific lung cell population to vaccinia infection.
However, TLR4 differentially activates an aspect(s) of antiviral
defense that is essential for early control of vaccinia replication and
spread. Understanding details of this differential regulation will
reveal strategies to enhance beneficial immunity to poxviruses and
suppress detrimental host responses.
Materials and Methods
Mice
TRIF
2/2 mice backcrossed to a C57BL/6 background were
originally developed by the S. Akira laboratory and were bred at
the University of Michigan. Wild-type (WT) C57BL/6J control
mice were obtained from The Jackson Laboratory. Adult male and
female mice ages 7 to 9 wk old were used for experiments.
C3HeB/FeJ and C3H/HeJ mice were obtained from The Jackson
Laboratory. Adult male mice ages 6 to 10 wk old were used for
experiments. 17-wk-old mice were used as uninfected controls for
histological studies.
Vaccinia virus
We prepared stocks of Vac-GFL, a recombinant Western
Reserve (WR) vaccinia virus that expresses firefly luciferase and
GFP, and determined viral titers as described previously [13].
Viral titers in excised organs were analyzed by serial dilution on
Vero cells [15].
Cells
Vero cells were maintained as we previously have described
[15]. Primary bone marrow macrophages were obtained by
flushing the femurs and tibiae of mice with cold PBS. This
suspension was filtered through a 100 mm filter and a 40 mm filter.
Macrophages were cultured in Dulbecco’s modified Eagle medium
supplemented with 20% L929-cell-conditioned media, 10% heat-
inactivated fetal bovine serum, 1% L-glutamine, and 0.1%
penicillin-streptomycin. Macrophages were cultured 1 wk in this
media before performing experiments with them.
Animal procedures
All animal procedures were approved by the University of
Michigan Committee on the Use and Care of Animals. Mice were
infected i.n. with vaccinia virus as described previously [15].
Weights and rectal temperatures (Physitemp Instruments) were
recorded on conscious mice immediately before infection and on
each day throughout experiments.
Bioluminescence imaging
Bioluminescence imaging was performed on each day after
infection using an IVIS 200 system (Caliper). Imaging and data
analysis were performed as described previously [15].
Figure 12. TLR4 recognizes an endogenous ligand and
downregulates cytokine secretion. Control C3HeB/FeJ and TLR4
mutant C3H/HeJ bone marrow macrophages were treated with live or
UV-inactivated Vac-GFL at MOI=5 (5610
5 pfu). (A) Viral titers in
macrophage cultures treated with live virus. IL-6 (B) and TNF-a (C)
concentrations in supernatants measured by ELISA. For all combina-
tions of pairs of points, p,0.05 except the pair denoting TNF-a in
control cells treated with live vs. UV-inactivated virus at 6 hours post-
infection.
doi:10.1371/journal.ppat.1000153.g012
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To prepare lungs for histology, mice were euthanized on days 3
and 5 post-infection, and lungs were inflated with 1 mL of 10%
formalin in PBS. Lungs were excised, preserved in 10% formalin
overnight or longer, and then transferred to 70% ethanol solution.
Fixed tissues were paraffin embedded and sectioned by the
Morphology Core Facility at the University of Michigan. Tissue
sections were stained with Gill’s hematoxylin and counterstained
with eosin. Sites of viral replication in the lungs were identified by
immunohistochemistry, based on detection of GFP from Vac-
GFL. Paraffin-embedded lung sections were stained using the
Vector Laboratories ABC staining kit. Tissue sections were stained
with rabbit polyclonal anti-GFP antibody (1/500 dilution)
(Invitrogen) and goat anti-rabbit secondary antibody (1/200
dilution; Vector Laboratories). Blocking solution consisted a 1/
67 dilution of goat serum in PBS with 250 mM total NaCl.
To quantify foci of inflammation in lung sections, we analyzed
transverse lung sections through comparable portions of the upper
and lower lobes of each lung. Sections were viewed under a 46
objective, and numbers of inflammatory foci were counted. Mean
values for numbers of foci and SEM were calculated.
Serum and tissue cytokines
Blood was obtained from the abdominal aorta of euthanized
mice and collected into heparinized tubes. Plasma was separated
from cells by centrifugation. Bronchoalveolar lavage of TRIF
2/2
mice was performed by intratracheal instillation and withdrawal of
1 mL PBS in lungs of euthanized mice. Plasma and bronchoal-
veolar lavage fluid concentrations of TNF-a, IL-6, and MCP-1
were determined by ELISA performed by the University of
Michigan Cancer Center Cellular Immunology Core Facility.
Concentrations of IFN-b were measured by ELISA (PBL
Biomedical Laboratories) according to the manufacturer’s instruc-
tions.
Lungs were harvested on day 3 or 5 post-infection and
homogenized in 5 mL PBS with a Polytron tissue homogenizer
(Brinkmann). Lung homogenates were centrifuged at 21116g for
10 minutes at 4uC. Supernatants were removed and concentra-
tions of TNF-a, IL-6, and MCP-1 measured by ELISA as
described above.
Flow cytometry
Lungs were excised on day 3 or 5 post-infection and
disaggregated by mechanical disruption in a blender (VWR).
Cells were counted and analyzed by flow cytometry as described
previously [31]. The following mAbs obtained from BD
Pharmingen were used: RM4-4 (anti-murine CD4, rat IgG2b),
53-6.72 (anti-murine CD8, rat IgG2b), 1D3 (anti-murine CD19,
rat IgG2a),M1/70 (anti-murine CD11b, rat IgG2b), HL3 (anti-
murine CD11c, hamster IgG1), 2.4G2 (anti-murine CD16/CD32
Fc block, rat IgG2b), 30-F11 (anti-murine CD45, rat IgG2b), and
RB6-8C5 (anti-murine Ly6G Gr-1, rat IgG2b). Monoclonal Abs
were primarily conjugated with FITC, PE, APC and APC-Cy7;
biotinylated Abs were visualized using streptavidin-PerCP-Cy5.5
(BD Pharmingen). Isotype matched control mAbs (BD Pharmin-
gen or eBioscience) were tested simultaneously in all experiments.
All samples were analyzed on the BD LSR II flow cytometer with
3 lasers (488 nm blue, 405 nm violet and 633 nm HeNe red).
CD45 APC-Cy7 and Invitrogen LIVE/DEAD Fixable Violet
Dead Cell Stain were added to all lung mince samples. Subset
analysis was performed on gated CD45-positive live cells. A
minimum of 10,000 cells were analyzed for each sample. For all
analyses, percentages for matched isotype control Abs were
subtracted from values obtained for staining with specific Abs
for individual markers.
UV inactivation of virus
Vac-GFL was UV-inactivated by irradiation for 90 s on
‘‘sterilize’’ setting in a GS Genelinker UV-chamber (BioRad)
following incubation in a Hank’s Balanced Salt Solution (HBSS)
solution containing 1.0 mg Psoralen according to the protocol of
Puhlmann and colleagues [32].
Statistics
Data were analyzed by t test for pairwise comparisons, using
Microsoft Excel or GraphPad Prism software. Differences with
p,0.05 were regarded as statistically significant.
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